Detalhe da pesquisa
1.
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med
; 387(21): 1957-1968, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346079
2.
Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals.
J Antimicrob Chemother
; 79(5): 1126-1132, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38530862
3.
High prevalence of high-risk HPV genotypes in individuals attending an infectious diseases clinic from 2018 to 2022 in Milan, Italy.
J Med Virol
; 96(1): e29370, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38197518
4.
Early administration of nirmatrelvir/ritonavir leads to faster negative SARS-CoV-2 nasal swabs than monoclonal antibodies in COVID 19 patients at high-risk for severe disease.
Virol J
; 21(1): 68, 2024 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38509536
5.
First imported case of Candida auris infection in Milan, Italy: genomic characterisation.
Infection
; 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38557967
6.
Unexpected CD4 decay, hidden adherence gaps, resilience, and the need for long-acting therapy in a single HIV outpatients' cohort.
AIDS Care
; : 1-6, 2024 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38170878
7.
Vaccination strategies for high-risk and fragile populations in Lombardy (Italy): a region-wide assessment of hospital-based models and best practices.
Ann Ig
; 36(2): 215-226, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38299733
8.
Long-Acting Cabotegravir and Rilpivirine Dosed Every 2 Months in Adults With Human Immunodeficiency Virus 1 Type 1 Infection: 152-Week Results From ATLAS-2M, a Randomized, Open-Label, Phase 3b, Noninferiority Study.
Clin Infect Dis
; 76(9): 1646-1654, 2023 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36660819
9.
Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.
N Engl J Med
; 382(12): 1112-1123, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-32130809
10.
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age.
HIV Med
; 24(1): 27-36, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35527425
11.
Pillars of long-term antiretroviral therapy success.
Pharmacol Res
; 196: 106898, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37648103
12.
Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: a retrospective multicenter cohort study.
Infection
; 51(1): 129-136, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687293
13.
Phase IIa Proof-of-Concept Evaluation of the Antiviral Efficacy, Safety, Tolerability, and Pharmacokinetics of the Next-Generation Maturation Inhibitor GSK3640254.
Clin Infect Dis
; 75(5): 786-794, 2022 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996113
14.
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 48-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study.
Lancet
; 396(10267): 1994-2005, 2021 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33308425
15.
Implementation of HCV screening in the 1969-1989 birth-cohort undergoing COVID-19 vaccination.
Liver Int
; 42(5): 1012-1016, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220667
16.
Mortality among Italians and immigrants with COVID-19 hospitalised in Milan, Italy: data from the Luigi Sacco Hospital registry.
BMC Infect Dis
; 22(1): 63, 2022 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35045808
17.
Isolation of viable monkeypox virus from anal and urethral swabs, Italy, May to July 2022.
Euro Surveill
; 27(36)2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36082684
18.
Preferences of PLWH and of clinicians for HIV treatment aimed at long-term success.
New Microbiol
; 45(4): 308-319, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538295
19.
Positive predictive value of sustained virologic response 4 weeks posttreatment for achieving sustained virologic response 12 weeks posttreatment in patients receiving glecaprevir/pibrentasvir in Phase 2 and 3 clinical trials.
J Viral Hepat
; 28(11): 1635-1642, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34448313
20.
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
J Med Virol
; 93(3): 1766-1769, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881014